Reduced expression of SRC family kinases decreases PI3K activity in NBS1-/- lymphoblasts

Biochemical and Biophysical Research Communications

Volumn 377, Issue 1, 2008, Pages 181-186

  Sagan, Daniel ^a   Eckardt Schupp, Friederike ^a   Eichholtz Wirth, Hedda ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

HCK; LCK; NBS1; PI3K; SFK

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LYMPHOBLAST; NIJMEGEN BREAKAGE SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; HUMANS; NIJMEGEN BREAKAGE SYNDROME; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PYRIMIDINES; SRC-FAMILY KINASES; TYROSINE;

EID: 54449100623     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.098     Document Type: Article

References (29)

1. Digweed M., and Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst.) 3 (2004) 1207-1217
2. Frappart P.O., Tong W.M., Demuth I., Radovanovic I., Herceg Z., Aguzzi A., Digweed M., and Wang Z.Q. An essential function for NBS1 in the prevention of ataxia and cerebellar defects. Nat. Med. 11 (2005) 538-544
3. Sagan D., Mortl S., Muller I., Eckardt-Schupp F., and Eichholtz-Wirth H. Enhanced CD95-mediated apoptosis contributes to radiation hypersensitivity of NBS lymphoblasts. Apoptosis 12 (2007) 753-767
4. The International Nijmegen Breakage Syndrome Study Group, Nijmegen breakage syndrome, Arch. Dis. Child 82 (2000) 400-406.
5. Lavin M.F. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26 (2007) 7749-7758
6. Chen Y.C., Chiang H.Y., Yang M.H., Chen P.M., Chang S.Y., Teng S.C., Vanhaesebroeck B., and Wu K.J. Activation of phosphoinositide 3-kinase by the NBS1 DNA repair protein through a novel activation motif. J. Mol. Med. 86 (2008) 401-412
7. Chen Y.C., Su Y.N., Chou P.C., Chiang W.C., Chang M.C., Wang L.S., Teng S.C., and Wu K.J. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 280 (2005) 32505-32511
8. Yang M.H., Chiang W.C., Chou T.Y., Chang S.Y., Chen P.M., Teng S.C., and Wu K.J. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin. Cancer Res. 12 (2006) 507-515
9. Bader A.G., Kang S., Zhao L., and Vogt P.K. Oncogenic PI3K deregulates transcription and translation. Nat. Rev. Cancer 5 (2005) 921-929
10. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
11. Hawkins P.T., Anderson K.E., Davidson K., and Stephens L.R. Signalling through Class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 34 (2006) 647-662
12. Barthel A., and Klotz L.O. Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress. Biol. Chem. 386 (2005) 207-216
13. Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim. Biophys. Acta 1784 (2008) 56-65
14. Lahair M.M., Howe C.J., Rodriguez-Mora O., McCubrey J.A., and Franklin R.A. Molecular pathways leading to oxidative stress-induced phosphorylation of Akt. Antioxid. Redox Signal. 8 (2006) 1749-1756
15. Sinha S., and Corey S.J. Implications for Src kinases in hematopoiesis: signal transduction therapeutics. J. Hematother. Stem Cell Res. 8 (1999) 465-480
16. von Willebrand M., Baier G., Couture C., Burn P., and Mustelin T. Activation of phosphatidylinositol-3-kinase in Jurkat T cells depends on the presence of the p56lck tyrosine kinase. Eur. J. Immunol. 24 (1994) 234-238
17. Varon R., Vissinga C., Platzer M., Cerosaletti K.M., Chrzanowska K.H., Saar K., Beckmann G., Seemanova E., Cooper P.R., Nowak N.J., Stumm M., Weemaes C.M., Gatti R.A., Wilson R.K., Digweed M., Rosenthal A., Sperling K., Concannon P., and Reis A. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93 (1998) 467-476
18. Ueki K., Algenstaedt P., Mauvais-Jarvis F., and Kahn C.R. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit. Mol. Cell. Biol. 20 (2000) 8035-8046
19. D. Sagan, Untersuchungen zur Strahlensensitivität von NBS Zellen, Department Biologie, Ludwig Maximilians Universität München, 2006.
20. Cuevas B.D., Lu Y., Mao M., Zhang J., LaPushin R., Siminovitch K., and Mills G.B. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276 (2001) 27455-27461
21. Hayashi H., Kamohara S., Nishioka Y., Kanai F., Miyake N., Fukui Y., Shibasaki F., Takenawa T., and Ebina Y. Insulin treatment stimulates the tyrosine phosphorylation of the alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase in vivo. J. Biol. Chem. 267 (1992) 22575-22580
22. Hayashi H., Nishioka Y., Kamohara S., Kanai F., Ishii K., Fukui Y., Shibasaki F., Takenawa T., Kido H., Katsunuma N., et al. The alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase is phosphorylated at tyrosines 368, 580, and 607 by the insulin receptor. J. Biol. Chem. 268 (1993) 7107-7117
23. Foukas L.C., Beeton C.A., Jensen J., Phillips W.A., and Shepherd P.R. Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo. Mol. Cell. Biol. 24 (2004) 966-975
24. von Willebrand M., Williams S., Saxena M., Gilman J., Tailor P., Jascur T., Amarante-Mendes G.P., Green D.R., and Mustelin T. Modification of phosphatidylinositol 3-kinase SH2 domain binding properties by Abl- or Lck-mediated tyrosine phosphorylation at Tyr-688. J. Biol. Chem. 273 (1998) 3994-4000
25. Bromann P.A., Korkaya H., and Courtneidge S.A. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23 (2004) 7957-7968
26. Maser R.S., Zinkel R., and Petrini J.H. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat. Genet. 27 (2001) 417-421
27. Hoshino K., Quintas-Cardama A., Yang H., Sanchez-Gonzalez B., and Garcia-Manero G. Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia. Leukemia 21 (2007) 906-911
28. Tedoldi S., Mottok A., Ying J., Paterson J.C., Cui Y., Facchetti F., an Krieken J.H., Ponzoni M., Ozkal S., Masir N., Natkunam Y., Pileri S., Hansmann M.L., Mason D., Tao Q., and Marafioti T. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. J. Pathol. 213 (2007) 429-440
29. Ushmorov A., Leithauser F., Sakk O., Weinhausel A., Popov S.W., Moller P., and Wirth T. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. Blood 107 (2006) 2493-2500